
Nasal – GHK-Cu / KPV 50mg / 10mg
July 7, 2026
Nasal – GLP-2 Dual Agonist GLP-1 + GIP 20mg
July 7, 2026Research GLP-1 analog for incretin biology, receptor binding, glucose-homeostasis models, peptide stability, and endocrine signaling studies.
Be the first to review “Nasal – GLP-1 Single Agonist 20mg” Cancel reply
Related products
-
Nasal – GLP-2 Dual Agonist GLP-1 + GIP 40mg
Call for PriceHigher-strength GLP-1/GIP dual agonist research spray for incretin receptor signaling, metabolic regulation, and acylated peptide studies.
-
Nasal – GLP-2 Dual Agonist GLP-1 + GIP 20mg
Call for PriceDual GLP-1/GIP agonist research spray for studying incretin receptor activation, metabolic pathway integration, and peptide engineering.




Reviews
There are no reviews yet.